Zydus Lifesciences Limited (ZYDUSLIFE.BO)
INR 885.45
(-0.25%)
INR 885.45
(-0.25%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 190.21 Billion INR | 12.7% |
| 2023 | 168.77 Billion INR | 13.83% |
| 2022 | 148.27 Billion INR | 4.97% |
| 2021 | 141.25 Billion INR | 2.27% |
| 2020 | 138.12 Billion INR | 8.34% |
| 2019 | 127.48 Billion INR | 10.08% |
| 2018 | 115.81 Billion INR | 26.33% |
| 2017 | 91.67 Billion INR | -2.75% |
| 2016 | 94.26 Billion INR | 8.96% |
| 2015 | 86.51 Billion INR | 19.76% |
| 2014 | 72.24 Billion INR | 13.63% |
| 2013 | 63.57 Billion INR | 20.79% |
| 2012 | 52.63 Billion INR | 17.89% |
| 2011 | 44.64 Billion INR | 24.92% |
| 2010 | 35.74 Billion INR | 22.09% |
| 2009 | 29.27 Billion INR | 29.19% |
| 2008 | 22.66 Billion INR | 26.91% |
| 2007 | 17.85 Billion INR | 23.54% |
| 2006 | 14.45 Billion INR | 16.28% |
| 2005 | 12.43 Billion INR | 3.91% |
| 2004 | 11.96 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 53.66 Billion INR | 23.54% |
| 2024 Q2 | 42.58 Billion INR | -15.72% |
| 2024 FY | 190.21 Billion INR | 12.7% |
| 2024 Q3 | 43.43 Billion INR | 2.0% |
| 2024 Q1 | 50.52 Billion INR | 4.13% |
| 2023 Q2 | 39.42 Billion INR | 0.5% |
| 2023 FY | 168.77 Billion INR | 13.83% |
| 2023 Q4 | 48.52 Billion INR | 16.65% |
| 2023 Q3 | 41.59 Billion INR | 5.51% |
| 2023 Q1 | 39.22 Billion INR | 6.64% |
| 2022 Q1 | 38.93 Billion INR | 3.67% |
| 2022 FY | 148.27 Billion INR | 4.97% |
| 2022 Q4 | 36.78 Billion INR | 4.24% |
| 2022 Q3 | 35.29 Billion INR | -3.64% |
| 2022 Q2 | 36.62 Billion INR | -5.94% |
| 2021 Q2 | 36.01 Billion INR | 5.17% |
| 2021 FY | 141.25 Billion INR | 2.27% |
| 2021 Q1 | 34.24 Billion INR | 3.41% |
| 2021 Q4 | 37.56 Billion INR | 4.59% |
| 2021 Q3 | 35.91 Billion INR | -0.27% |
| 2020 Q2 | 32.44 Billion INR | -7.21% |
| 2020 Q1 | 34.96 Billion INR | 5.45% |
| 2020 FY | 138.12 Billion INR | 8.34% |
| 2020 Q4 | 33.11 Billion INR | -6.32% |
| 2020 Q3 | 35.34 Billion INR | 8.95% |
| 2019 Q2 | 29.61 Billion INR | 2.33% |
| 2019 Q4 | 33.15 Billion INR | -7.33% |
| 2019 Q1 | 28.93 Billion INR | -10.97% |
| 2019 Q3 | 35.77 Billion INR | 20.83% |
| 2019 FY | 127.48 Billion INR | 10.08% |
| 2018 Q1 | 21.85 Billion INR | -11.4% |
| 2018 Q3 | 32.59 Billion INR | 1.18% |
| 2018 Q4 | 32.5 Billion INR | -0.3% |
| 2018 FY | 115.81 Billion INR | 26.33% |
| 2018 Q2 | 32.21 Billion INR | 47.44% |
| 2017 Q1 | 22.87 Billion INR | -2.03% |
| 2017 FY | 91.67 Billion INR | -2.75% |
| 2017 Q4 | 24.66 Billion INR | 6.73% |
| 2017 Q3 | 23.11 Billion INR | -1.78% |
| 2017 Q2 | 23.53 Billion INR | 2.89% |
| 2016 Q2 | 22.66 Billion INR | -0.03% |
| 2016 FY | 94.26 Billion INR | 8.96% |
| 2016 Q3 | 22.67 Billion INR | 0.07% |
| 2016 Q1 | 22.67 Billion INR | -5.85% |
| 2016 Q4 | 23.34 Billion INR | 2.94% |
| 2015 Q2 | 20.63 Billion INR | 2.14% |
| 2015 Q3 | 21.66 Billion INR | 4.97% |
| 2015 Q4 | 24.07 Billion INR | 11.17% |
| 2015 Q1 | 20.2 Billion INR | -2.88% |
| 2015 FY | 86.51 Billion INR | 19.76% |
| 2014 Q3 | 18.38 Billion INR | 8.23% |
| 2014 FY | 72.24 Billion INR | 13.63% |
| 2014 Q4 | 20.8 Billion INR | 13.18% |
| 2014 Q2 | 16.98 Billion INR | 5.65% |
| 2014 Q1 | 16.07 Billion INR | -0.25% |
| 2013 Q1 | 15.16 Billion INR | 23.79% |
| 2013 Q2 | 15.12 Billion INR | -0.24% |
| 2013 Q3 | 15.61 Billion INR | 3.21% |
| 2013 FY | 63.57 Billion INR | 20.79% |
| 2013 Q4 | 16.11 Billion INR | 3.24% |
| 2012 Q2 | 12.19 Billion INR | 0.0% |
| 2012 Q3 | 13.83 Billion INR | 13.41% |
| 2012 Q4 | 12.24 Billion INR | -11.46% |
| 2012 FY | 52.63 Billion INR | 17.89% |
| 2011 FY | 44.64 Billion INR | 24.92% |
| 2010 FY | 35.74 Billion INR | 22.09% |
| 2009 FY | 29.27 Billion INR | 29.19% |
| 2008 FY | 22.66 Billion INR | 26.91% |
| 2007 FY | 17.85 Billion INR | 23.54% |
| 2006 FY | 14.45 Billion INR | 16.28% |
| 2005 FY | 12.43 Billion INR | 3.91% |
| 2004 FY | 11.96 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alkem Laboratories Limited | 126.67 Billion INR | -50.159% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -4415.699% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | -211.21% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | -1368.241% |
| Aurobindo Pharma Limited | 287.04 Billion INR | 33.733% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -47411.821% |
| Eris Lifesciences Limited | 20.09 Billion INR | -846.747% |
| FDC Limited | 19.42 Billion INR | -879.004% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | -733.102% |
| Ipca Laboratories Limited | 76.22 Billion INR | -149.547% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -9014.192% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -37624.978% |
| Laurus Labs Limited | 50.01 Billion INR | -280.293% |
| Lupin Limited | 200.1 Billion INR | 4.944% |
| Medicamen Biotech Limited | 1.79 Billion INR | -10508.389% |
| Medico Remedies Limited | 1.44 Billion INR | -13025.454% |
| Megasoft Limited | 373.95 Million INR | -50766.018% |
| NATCO Pharma Limited | 40.02 Billion INR | -375.3% |
| Piramal Pharma Limited | 81.71 Billion INR | -132.788% |
| Sigachi Industries Limited | 3.98 Billion INR | -4667.818% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | -1435.986% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 60.778% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -1709.239% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -7237.296% |
| Themis Medicare Limited | 3.81 Billion INR | -4882.57% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | -79.356% |
| Valiant Laboratories Limited | 1.82 Billion INR | -10348.09% |
| Wanbury Limited | 5.75 Billion INR | -3204.353% |
| Windlas Biotech Limited | 6.3 Billion INR | -2914.711% |
| ZIM Laboratories Limited | 3.67 Billion INR | -5076.983% |
| Ajanta Pharma Limited | 42.08 Billion INR | -351.956% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | -1385.011% |
| Achyut Healthcare Limited | 61.36 Million INR | -309852.908% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -18131.178% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -25078.932% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | -947.725% |
| Alpa Laboratories Limited | 1.08 Billion INR | -17392.804% |
| Gufic Biosciences Limited | 8.06 Billion INR | -2258.04% |
| Ind-Swift Limited | 5.02 Billion INR | -3685.613% |
| Indoco Remedies Limited | 17.89 Billion INR | -962.98% |
| Hester Biosciences Limited | 3.04 Billion INR | -6145.854% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -2369.539% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -3917.909% |
| RPG Life Sciences Limited | 5.82 Billion INR | -3168.018% |
| Mankind Pharma Limited | 103.34 Billion INR | -84.053% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | -61.02% |
| Unichem Laboratories Limited | 16.57 Billion INR | -1047.66% |
| Bal Pharma Limited | 3.39 Billion INR | -5507.43% |
| Strides Pharma Science Limited | 40.51 Billion INR | -369.536% |
| Venus Remedies Limited | 5.91 Billion INR | -3116.081% |
| Jubilant Pharmova Limited | 67.02 Billion INR | -183.78% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 31.863% |
| Divi's Laboratories Limited | 78.45 Billion INR | -142.467% |
| Nectar Lifesciences Limited | 16.84 Billion INR | -1029.485% |
| Shilpa Medicare Limited | 11.51 Billion INR | -1551.741% |
| Aarti Drugs Limited | 25.28 Billion INR | -652.261% |
| IOL Chemicals and Pharmaceuticals Limited | 21.18 Billion INR | -797.681% |
| Suven Life Sciences Limited | 116.92 Million INR | -162575.641% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.84 Billion INR | -445.938% |
| Hikal Limited | 17.84 Billion INR | -965.869% |
| Procter & Gamble Health Limited | 11.51 Billion INR | -1552.233% |
| Sequent Scientific Limited | 13.69 Billion INR | -1288.703% |
| Novartis India Limited | 3.35 Billion INR | -5576.873% |
| Granules India Limited | 45.06 Billion INR | -322.103% |
| Wockhardt Limited | 27.89 Billion INR | -582.019% |
| Brooks Laboratories Limited | 794.86 Million INR | -23830.599% |
| Neuland Laboratories Limited | 15.58 Billion INR | -1120.437% |
| Morepen Laboratories Limited | 17.01 Billion INR | -1017.663% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -12221.819% |
| Mangalam Drugs & Organics Limited | 3.68 Billion INR | -5060.545% |